Nyhedsanalysen

Novo Nordisk Fonden donerer en milliard til det kommende National Genom Center

Novo Nordisk Fonden donerer en milliard til det kommende National Genom Center. Det besluttede fondens bestyrelse torsdag aften. Centeret har til formål at udbrede brugen af såkaldt personlig medicin, der er medicin tilpasset den enkelte patient. Tilskuddet fra Novo-fonden skal bruges til både etablering og drift af centeret.

Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00Silicon Valley00:00Mexico City00:00New York00:00Sao Paulo00:00Nuuk00:00Bangui00:00Linköping00:00Kyjiv00:00Kabul00:00Mumbai00:00Hong Kong00:00Shanghai00:00Sydney00:00Fransk Polynesien00:00

1

2

3

4

5

6

7

8

9

10

11

12